Autotransfusion in women with ruptured ectopic pregnancy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202504666239585

Enrollment

Registered

2025-04-03

Start date

2025-03-24

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Haematological Disorders Pregnancy and Childbirth Ruptured ectopic pregnancy

Interventions

Autotransfusion of blood

Routine care without autotransfusion

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Stable participants with substantial haemoperitoneum from ectopic pregnancy. Women 18 years old or more

Exclusion criteria

Exclusion criteria: Non-ruptured ectopic pregnancy

Design outcomes

Primary

Measure	Time frame
Allogeneic blood transfusion or death;Allogeneic blood transfusion or death	—

Secondary

Measure	Time frame
• Time from enrolment to laparotomy • hemodynamic stability 30 and 60 minutes after the operation as measured by blood pressure, pulse and shock index • Death • Complications: Allergic reaction, Sepsis and ICU admission • Number of donor transfusions • Volume of autotransfusion • Cost • Donor blood transfusion or postoperative anaemia	—

Countries

South Africa

Contacts

Public ContactMandisa SingataMadliki

Researcher

mandisa.singata@gmail.com+27824201743

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026